secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORDSON CORP (NDSN)
CIK:        0000072331
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001193125-24-204098
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordson completes acquisition of Atrion for $460 per share; borrows $825M
-------------------------------------------------------------------------

- Completed acquisition of Atrion Corp. on Aug 21, 2024; stockholders received $460.00 per share in cash.
- Borrowed $500M under a 364-day term loan and $325M under revolving credit facility to fund the merger.
- Atrion specializes in medical infusion fluid delivery and cardiovascular solutions, expanding Nordson's medical portfolio.
- Atrion survives as a wholly owned subsidiary of Nordson after the merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72331/000119312524204098/0001193125-24-204098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72331/000119312524204098/d874837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-204098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer